Loading...
Loading...
Among the 6 tracked institutional investors we monitor, PLX (PROTALIX BIOTHERAPEUTICS INC) is held with a combined value of $13.65M across 6,375,634 shares. The largest holder is BlackRock, Inc. with a position worth $7.85M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$13.65M
Total Shares Held
6,375,634
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $7.85M | 0.00% | -0.8% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $2.66M | 0.00% | -3.0% |
| 3 | STATE STREET CORP | $2.11M | 0.00% | +66.2% |
| 4 | VANGUARD GROUP INC | $879.39K | 0.00% | New |
| 5 | CITADEL ADVISORS LLC | $151.03K | 0.00% | -80.8% |
| 6 | FMR LLC | $6.30K | 0.00% | +25.5% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of PLX with a position worth $7.85M, representing 0.00% of their portfolio. In total, 6 institutional investors hold PLX with a combined value of $13.65M.
In the most recent quarter, 1 fund opened a new position in PLX. Additionally, 2 increased their holdings and 3 reduced their positions.
Institutional investors hold $13.65M worth of PLX stock across 6 positions. The largest institutional holder is BlackRock, Inc. with $7.85M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For PLX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their PLX positions.